TAUROHYODEOXYCHLOIC ACID
Taurohyodeoxycholic acid is a bile acid conjugate involved in lipid digestion and studied for hepatoprotective and metabolic effects. It stabilizes cell membranes and modulates bile flow. Side effects may include diarrhea, abdominal discomfort, and rare elevations in liver enzymes at high doses.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP Manufacturers
Let us handle your sourcing / supply activities. For years we have sourced specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
We are committed to supplying high-quality GMP products with logistics accoring to GDP regulations
Product Description
Mechanism of Action
TAUROHYODEOXYCHLOIC ACID (ID 27564) exhibits a highly distributed biochemical activity matrix spanning multi‑axis signalling disruption, enzymatic‑cascade interference, mitochondrial‑network recalibration, cytoskeletal remodelling, redox‑system modulation, ion‑flux redistribution and transcription‑factor pathway realignment. Its conformational topology enables interaction with catalytic cores, allosteric domains, transmembrane helices, hydrophobic receptor cavities, nucleotide‑binding pockets and multiprotein scaffolding structures. This generates system‑wide modulation across metabolic, genomic, structural and electrophysiological domains.
At the signalling level, TAUROHYODEOXYCHLOIC ACID may reshape phosphorylation gradients, modify propagation dynamics across MAPK/ERK/JNK/p38 axes, alter PI3K–AKT survival signalling, shift G‑protein coupling states, recalibrate intracellular Ca²⁺ microdomains, and modulate IP₃/DAG and cAMP‑PKA signalling amplitudes. Mitochondrial effects include ETC‑complex rebalancing, ATP‑turnover adjustment, ROS‑leakage threshold modulation and membrane‑potential polarity shifts. Its multi‑node regulation enables deep experimental interrogation of stress‑adaptation pathways and metabolic‑response thresholds.
High‑Resolution Research Applications
- Ultra‑scale kinome interference mapping & catalytic‑cascade simulation
- High‑fidelity receptor–ligand docking & conformational‑flow modelling
- Organelle cross‑talk modelling (UPR, mitochondrial/ER stress, mitophagy dynamics)
- Multi‑omics regulatory‑network reconstruction (RNA‑seq, metabolomics, proteomics, phosphoproteomics)
- Advanced cytoskeletal biomechanics (actin/tubulin turnover, tension‑mapping)
- Cell‑fate modelling across apoptosis, necroptosis, ferroptosis, parthanatos & autophagic flux axes
- AI‑enhanced SAR/QSAR molecular‑performance prediction
Toxicodynamics & Hazard Profile
- Accelerated ROS accumulation & antioxidant‑system saturation
- Mitochondrial fragmentation or ETC‑chain destabilisation
- Severe Ca²⁺/Na⁺/K⁺ ionic‑flux dysregulation
- Cytoskeletal depolymerisation & loss of mechanical integrity
- Membrane damage, permeability shifts & lipid‑bilayer thinning
- Inflammatory overactivation via NF‑κB, STAT & IRF signalling
- Multiple programmed‑cell‑death pathway activation
- Epigenetic distortions (methylation drift, acetylation imbalance)
For expert laboratory research only — not intended for biological exposure.
Datasheet
| Molecular Weight | g/mol |
|---|---|
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| IUPAC/Chemical Name | Taurohyodeoxycholic acid |
| References | Not available; |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
